Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia
Status:
Unknown status
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The main goal of this study is to assess the safety and tolerability of RAD001 in combination
with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy.
The secondary goals are to investigate the likely causes of drug response or failure.